Quantum BioPharma Ltd. Files 6-K with SEC
Ticker: QNTM · Form: 6-K · Filed: Oct 7, 2024 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Oct 7, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, registration-statement, company-update
TL;DR
Quantum BioPharma filed a 6-K on Oct 7, incorporating a press release into their F-3 registration. Keep an eye on disclosures.
AI Summary
Quantum BioPharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on October 7, 2024, incorporating by reference a press release issued on the same date. This filing is part of their Registration Statement on Form F-3 (SEC File No. 333-276264). The company is incorporated in Canada and its fiscal year ends on December 31.
Why It Matters
This filing indicates ongoing reporting and potential updates related to Quantum BioPharma's securities, which could impact investors monitoring the company's regulatory compliance and disclosures.
Risk Assessment
Risk Level: low — This is a routine SEC filing (Form 6-K) that primarily incorporates previously issued information, suggesting no immediate new material events.
Key Numbers
- 001-39152 — SEC File Number (Identifies the company's filing history with the SEC.)
- 333-276264 — Form F-3 SEC File Number (References the company's active registration statement.)
Key Players & Entities
- Quantum BioPharma Ltd. (company) — Registrant
- FSD Pharma Inc. (company) — Former company name
- October 7, 2024 (date) — Filing date and press release date
- Form F-3 (document) — Registration statement referenced
- SEC File No. 333-276264 (document) — Registration statement file number
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to incorporate by reference a press release issued by Quantum BioPharma Ltd. on October 7, 2024, into its existing Registration Statement on Form F-3.
What was Quantum BioPharma Ltd.'s former name?
Quantum BioPharma Ltd.'s former name was FSD Pharma Inc., with a date of name change on March 27, 2019.
When is Quantum BioPharma Ltd.'s fiscal year end?
Quantum BioPharma Ltd.'s fiscal year ends on December 31.
What is the SEC file number for the referenced Registration Statement?
The SEC file number for the referenced Registration Statement on Form F-3 is 333-276264.
Where is Quantum BioPharma Ltd. incorporated and what is its principal executive office address?
Quantum BioPharma Ltd. is incorporated in Canada, and its principal executive office is located at 199 Bay St., Suite 4000, Toronto, Ontario M5L 1A9, Canada.
Filing Stats: 252 words · 1 min read · ~1 pages · Grade level 11.2 · Accepted 2024-10-07 07:32:15
Filing Documents
- fsd_6k.htm (6-K) — 11KB
- fsd_ex991.htm (EX-99.1) — 17KB
- fsd_ex991img2.jpg (GRAPHIC) — 8KB
- 0001654954-24-012731.txt ( ) — 40KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: October 7, 2024 By: /s/ Donal Carroll Donal Carroll, Chief Financial Officer 3 EXHIBIT INDEX Exhibit Description Exhibit 99.1 Press Release dated October 7, 2024 4